Skip to main content
logo
Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.6558
+0.0166 (2.60%)
At close: Jan 2, 2026, 4:00 PM EST
0.6400
-0.0158 (-2.41%)
After-hours: Jan 2, 2026, 4:08 PM EST

Cytosorbents Revenue

Cytosorbents had revenue of $9.49M in the quarter ending September 30, 2025, with 10.12% growth. In the year 2024, Cytosorbents had annual revenue of $35.59M with 14.51% growth.

Revenue (ttm)
$35.59M
Revenue Growth
+14.51%
P/S Ratio
1.04
Revenue / Employee
$248,185
Employees
149
Market Cap
41.19M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202435.59M4.51M14.51%
Dec 31, 202331.08M-3.60M-10.39%
Dec 31, 202234.69M-8.48M-19.64%
Dec 31, 202143.17M2.16M5.27%
Dec 31, 202041.00M16.06M64.35%
Dec 31, 201924.95M2.45M10.87%
Dec 31, 201822.50M7.35M48.53%
Dec 31, 201715.15M5.62M59.02%
Dec 31, 20169.53M4.74M98.84%
Dec 31, 20154.79M668.79K16.22%
Dec 31, 20144.12M1.70M70.18%
Dec 31, 20132.42M1.08M80.40%
Dec 31, 20121.34M1.31M3,622.31%
Dec 31, 201136.08K--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

CTSO News

More News